Patrick F Latterell - Net Worth and Insider Trading

Patrick F Latterell Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Patrick F Latterell owns 3 companies in total, including Evoke Pharma Inc (EVOK) , OncoMed Pharmaceuticals Inc (OMED) , and Fresh Tracks Therapeutics Inc (FRTX) .

Click here to see the complete history of Patrick F Latterell’s form 4 insider trades.

Insider Ownership Summary of Patrick F Latterell

Ticker	Comapny	Transaction Date	Type of Owner
EVOK	Evoke Pharma Inc	2013-09-24	10 percent owner
OMED	OncoMed Pharmaceuticals Inc	2013-07-23	10 percent owner
FRTX	Fresh Tracks Therapeutics Inc	2003-05-21	director

Patrick F Latterell Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Patrick F Latterell Ownership Network

Ownership Network List of Patrick F Latterell

No Data

Ownership Network Relation of Patrick F Latterell

Patrick F Latterell Owned Company Details

What does Evoke Pharma Inc do?

Who are the key executives at Evoke Pharma Inc?

Patrick F Latterell is the 10 percent owner of Evoke Pharma Inc. Other key executives at Evoke Pharma Inc include director & President and CEO David A Gonyer , Exec VP & Chief Bus. Officer Matthew J D'onofrio , and 10 percent owner Lvp Gp Iii, Llc .

Evoke Pharma Inc (EVOK) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Evoke Pharma Inc (EVOK) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Evoke Pharma Inc (EVOK) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Evoke Pharma Inc (EVOK)'s detailed insider trading history can be found in Insider Trading Tracker table.

Evoke Pharma Inc Insider Transactions

No Available Data

What does OncoMed Pharmaceuticals Inc do?

Who are the key executives at OncoMed Pharmaceuticals Inc?

Patrick F Latterell is the 10 percent owner of OncoMed Pharmaceuticals Inc. Other key executives at OncoMed Pharmaceuticals Inc include See Remarks Sunil Patel , Chairman & CEO Paul J Hastings , and SVP & Chief Medical Officer Jakob Dupont .

OncoMed Pharmaceuticals Inc (OMED) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of OncoMed Pharmaceuticals Inc (OMED) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of OncoMed Pharmaceuticals Inc (OMED) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

OncoMed Pharmaceuticals Inc (OMED)'s detailed insider trading history can be found in Insider Trading Tracker table.

OncoMed Pharmaceuticals Inc Insider Transactions

No Available Data

What does Fresh Tracks Therapeutics Inc do?

Who are the key executives at Fresh Tracks Therapeutics Inc?

Patrick F Latterell is the director of Fresh Tracks Therapeutics Inc. Other key executives at Fresh Tracks Therapeutics Inc include Chief Medical Officer Monica E. Luchi , director & CHAIRMAN OF THE BOARD Reginald L Hardy , and General Counsel and CCO David R. Mcavoy .

Fresh Tracks Therapeutics Inc (FRTX) Insider Trades Summary

Over the past 18 months, Patrick F Latterell made no insider transaction in Fresh Tracks Therapeutics Inc (FRTX). Other recent insider transactions involving Fresh Tracks Therapeutics Inc (FRTX) include a net sale of 110 shares made by ,

In summary, during the past 3 months, insiders sold 0 shares of Fresh Tracks Therapeutics Inc (FRTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 110 shares of Fresh Tracks Therapeutics Inc (FRTX) were sold and 1,086,412 shares were bought by its insiders, resulting in a net purchase of 1,086,302 shares.

Fresh Tracks Therapeutics Inc (FRTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Fresh Tracks Therapeutics Inc Insider Transactions

No Available Data

Patrick F Latterell Mailing Address

Above is the net worth, insider trading, and ownership report for Patrick F Latterell. Currently GuruFocus does not have mailing address information for Patrick F Latterell.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.